Reference value of brachial-ankle pulse wave velocity for the eastern Chinese population and potential influencing factors

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 10, 2011, Pages 1000-1005

  Ai, Zi Sheng ^a   Li, Jue ^a   Liu, Zhong Min ^a   Fan, Hui Min ^a   Zhang, Dai Fu ^a   Zhu, Yun ^a   Zhang, Li Juan ^a   Zhu, Wen Qing ^a   Bao, Yan ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Age; Gender; Influencing factor; Pulse wave velocity; Reference value

Indexed keywords

TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BRACHIAL ANKLE PULSE WAVE VELOCITY; CHINESE; FEMALE; GROUPS BY AGE; HEART RATE; HUMAN; MALE; NORMAL HUMAN; PULSE WAVE; REFERENCE VALUE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 80053957312     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500108     Document Type: Article

References (30)

1. Gkaliagkousi E, Douma S. The pathogenesis of arterial stiffness and its prognostic value in essential hypertension and cardiovascular diseases. Hippokratia 2009; 13: 70-75.
2. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of allcause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
3. Asmar R, Rudnichi A, Blacher J, London GM, Safar ME. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens 2001; 14: 91-97.
4. Agabiti-Rosei E, Porteri E, Rizzoni D. Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag 2009; 5: 353-360.
5. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71: 202-210.
6. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983; 68: 50-58.
7. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663.
8. Lee NB, Park CG. Reproducibility of regional pulse wave velocity in healthy subjects. Korean J Intern Med 2009; 24: 19-23.
9. Maple-Brown LJ, Piers LS, O'Rourke MF, Celermajer DS, O'Dea K. Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. J Hypertens 2007; 25: 585-591.
10. Sato H, Hayashi J, Harashima K, Shimazu H, Kitamoto K. A population-based study of arterial stiffness index in relation to cardiovascular risk factors. J Atheroscler Thromb 2005; 12: 175-180.
11. Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, et al. Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus. J Atheroscler Thromb 2006; 13: 114-121.
12. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
13. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
14. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657.
15. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 2005; 19: 401-406.
16. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309.
17. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290: 898-904.
18. Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 1998; 97: 1095-1102.
19. Park SM, Seo HS, Lim HE, Shin SH, Park CG, Oh DJ, et al. Assessment of arterial stiffness index as a clinical parameter for atherosclerotic coronary artery disease. Circ J 2005; 69: 1218-1222.
20. Xu Y, WU Y, Li J, Ma W, Guo X, Luo Y, et al. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients. Hypertens Res 2008; 31: 1079-1085.
21. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-15.
22. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004; 173: 13-18.
23. Levenson J, Simon AC, Cambien FA, Beretti C. Cigarette smoking and hypertension. Factors independently associated with blood hyperviscosity and arterial rigidity. Arteriosclerosis 1987; 7: 572-577.
24. Toto-Moukouo JJ, Achimastos A, Asmar RG, Hugues CJ, Safar ME. Pulse wave velocity in patients with obesity and hypertension. Am Heart J 1986; 112: 136-140.
25. Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993; 27: 942-945.
26. Muramatsu J, Kobayashi A, Hasegawa N, Yokouchi S. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin. Atherosclerosis 1997; 130: 179-182.
27. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, et al. Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001; 19: 407-413.
28. Boutouyrie P, Laurent S, Briet M. Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs. Fundam Clin Pharmacol 2008; 22: 241-246.
29. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo- Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46: 1753-1760.
30. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-150.